Ard Tijsterman

Company: BiosanaPharma NV

Job title: Chief Executive Officer

Seminars:

Advancing End-to-End Continuous Manufacturing for Biologics & Biosimilars  12:00 pm

CM implementation hurdles when moving from development to phase III manufacturing  Regulatory assessment of CM CoGs is the driver for CM of Biosimilars & BiologicsRead more

day: Day One Track B AM